Yüklüyor......

Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.

Because of encouraging results when human leukocyte interferon was given for 5 to 7 days to treat early localized herpes zoster in patients with cancer, a small placebo-controlled, randomized, double-blind trial was set up involving only 48 h of therapy. In this trial, there was no effect on acute p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Merigan, T C, Gallagher, J G, Pollard, R B, Arvin, A M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1981
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC181382/
https://ncbi.nlm.nih.gov/pubmed/6166245
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!